Association between bone mineral density and C-reactive protein in a large population-based sample

Arthritis and Rheumatism

Volumn 64, Issue 8, 2012, Pages 2624-2631

  De Pablo, Paola ^a   Cooper, Mark S ^a   Buckley, Christopher D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CALCIFEDIOL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; STEROID; THIAZIDE DIURETIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BONE DENSITY; CARDIOVASCULAR DISEASE; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEALTH SURVEY; HISPANIC; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; STROKE; UNITED STATES; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BONE DENSITY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OSTEOPOROSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84864471422     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34474     Document Type: Article

References (42)

1. Hardy R, Cooper MS,. Bone loss in inflammatory disorders. J Endocrinol 2009; 201: 309-20.
2. Spector TD, Hall GM, McCloskey EV, Kanis JA,. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993; 306: 558.
3. Gough AK, Lilley J, Eyre S, Holder RL, Emery P,. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994; 344: 23-7.
4. Geusens P, Vosse D, van der Linden S,. Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol 2007; 19: 335-9.
5. Lane NE,. Therapy insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006; 2: 562-9.
6. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN,. The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study. Ann Intern Med 2000; 133: 795-9.
7. Loftus EV Jr, Crowson CS, Sandborn WJ, Tremaine WJ, O'Fallon WM, Melton LJ III,. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology 2002; 123: 468-75.
8. Barnes PJ, Celli BR,. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-85.
9. Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS,. Mechanisms of disease: the link between RANKL and arthritic bone disease. Nat Clin Pract Rheumatol 2005; 1: 47-54.
10. Takayanagi H,. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007; 7: 292-304.
11. Demis E, Roux C, Breban M, Dougados M,. Infliximab in spondylarthropathy-influence on bone density. Clin Exp Rheumatol 2002; 20: S185-6.
12. Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C,. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis 2003; 62: 347-9.
13. Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR,. The effect of anti-TNF-α therapy on spinal bone mineral density in patients with Crohn's disease. Ann N Y Acad Sci 2006; 1068: 543-56.
14. Lange U, Teichmann J, Muller-Ladner U, Strunk J,. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody: a prospective open-label pilot study. Rheumatology (Oxford) 2005; 44: 1546-8.
15. Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, et al. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1495-9.
16. Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M,. Bone metabolism changes during anti-TNF-α therapy in patients with active rheumatoid arthritis. Ann N Y Acad Sci 2006; 1069: 420-7.
17. Briot K, Garnero P, Le Henanff A, Dougados M, Roux C,. Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment. Ann Rheum Dis 2005; 64: 1137-40.
18. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, et al. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 2005; 16: 1263-71.
19. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G,. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 2008; 93: 1952-8.
20. Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K,. Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc 2005; 97: 329-33.
21. Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC, Spilsbury HJ, Box JD, et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 2006; 296: 1353-5.
22. Bhupathiraju SN, Alekel DL, Stewart JW, Hanson LN, Shedd KM, Reddy MB, et al. Relationship of circulating total homocysteine and C-reactive protein to trabecular bone in postmenopausal women. J Clin Densitom 2007; 10: 395-403.
23. Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, Petrangeli M, et al. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck Study. Arch Intern Med 2006; 166: 2495-501.
24. Centers for Disease Control and Prevention: National Center for Health Statistics. National Health and Nutrition Examination Survey data. URL:.
25. Centers for Disease Control and Prevention: National Center for Health Statistics. National Health and Nutrition Examination Survey: technical documentation for the 1999-2004 dual energy X-ray absorptiometry (DXA) multiple imputation data files. February 2008. URL:.
26. Centers for Disease Control and Prevention: National Center for Health Statistics. National Health and Nutrition Examination Survey questionnaire (or examination protocol, or laboratory protocol). URL:.
27. Ford ES, Giles WH, Dietz WH,. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
28. Hoffmann K, Bergmann MM,. Re: "Modeling smoking history: a comparison of different approaches." Comment on: Am J Epidemiol 2002;156:813-23. Am J Epidemiol 2003; 158: 393.
29. Dietrich T, Hoffmann K,. A comprehensive index for the modeling of smoking history in periodontal research. J Dent Res 2004; 83: 859-63.
30. Dietrich T, Garcia RI, de Pablo P, Schulze PC, Hoffmann K,. The effects of cigarette smoking on C-reactive protein concentrations in men and women and its modification by exogenous oral hormones in women. Eur J Cardiovasc Prev Rehabil 2007; 14: 694-700.
31. Leffondre K, Abrahamowicz M, Xiao Y, Siemiatycki J,. Modelling smoking history using a comprehensive smoking index: application to lung cancer. Stat Med 2006; 25: 4132-46.
32. Giovannucci E, Colditz G, Stampfer MJ, Rimm EB, Litin L, Sampson L, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 1991; 133: 810-7.
33. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498-504.
34. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-47.
35. Looker AC, Melton LJ III, Harris T, Borrud L, Shepherd J, McGowan J,. Age, gender, and race/ethnic differences in total body and subregional bone density. Osteoporos Int 2009; 20: 1141-9.
36. Cauley JA, Danielson ME, Boudreau RM, Forrest KY, Zmuda JM, Pahor M, et al, for the Health ABC Study. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 2007; 22: 1088-95.
37. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B,. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004; 116: 634-9.
38. Homik J, Suarez-Almazor ME, Shea B, Cranney A, Wells G, Tugwell P,. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000:CD000952.
39. Melton LJ III, Riggs BL, Achenbach SJ, Amin S, Camp JJ, Rouleau PA, et al. Does reduced skeletal loading account for age-related bone loss? J Bone Miner Res 2006; 21: 1847-55.
40. LeBlanc A, Lin C, Shackelford L, Sinitsyn V, Evans H, Belichenko O, et al. Muscle volume, MRI relaxation times (T2), and body composition after spaceflight. J Appl Physiol 2000; 89: 2158-64.
41. Orwoll ES, Oviatt SK, Mann T,. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 1990; 70: 1202-7.
42. Whyte MP,. Paget's disease of bone. N Engl J Med 2006; 355: 593-600.